Comments*

 
  • Media Relations

  • The New York Academy of Sciences to Host ‘Dual Use Research: H5N1 Influenza Virus and Beyond’

    Panel of scientists, publishers, and legal experts to discuss controversial studies on the avian influenza virus.

    Posted 1/23/2012

    NEW YORK, January 23, 2012—The US National Science Advisory Board for Biosecurity (NSABB) recently recommended that journals Nature and Science remove certain methodological details from controversial studies on the avian influenza virus (H5N1) to minimize the risk of these findings being misused by would-be bioterrorists. On February 2 from 6pm to 8pm, the Emerging Infectious Diseases & Microbiology Discussion Group of the New York Academy of Sciences presents Dual Use Research: H5N1 Influenza Virus and Beyond, a discussion between scientists, publishers, and legal experts that will explore the myriad issues surrounding the impending publication of these two studies and measures that will need to be undertaken to ensure the security of future such research.

    To weigh in on matters of censorship and public safety, W. Ian Lipkin, MD, Center for Infection & Immunity at Columbia University, will moderate a panel discussion with Arturo Casadevall, MD, PhD, Albert Einstein College of Medicine, and member, NSABB; Laurie Garrett, PhD, Council on Foreign Relations; Barbara R. Jasny, PhD, Science; Veronique Kiermer, PhD, Nature Publishing Group; Michael T. Osterholm, PhD, MPH, Center for Infectious Disease Research and Policy, University of Minnesota, and member, NSABB; Peter Palese, PhD, Mount Sinai School of Medicine; Vincent Racaniello, PhD, Columbia University; and Alan S. Ruldolph, PhD, Defense Threat Reduction Agency.

    "Scientific investigation into the biology of pathogens, host response, diagnostics, drugs, and vaccines is critical to reducing the burden of infectious diseases; thus, the challenge is to manage dual use research so as maximize benefit and minimize risk," says Lipkin. "Scientists have a responsibility to engage with one another and the larger community in thoughtfully addressing this challenge."

    "By attending this event, members of the audience will have an opportunity to understand viewpoints of a wide range of stakeholders, shape the discussion, and thereby influence the future of dual use research," adds Lipkin.

    The event, sponsored by the Center for Infection and Immunity at the Columbia University Mailman School of Public Health, is free for Academy members. Both members and non-members can register for the event here. Media must RSVP to Diana Friedman (dfriedman@nyas.org; 212.298.8645).


    About the New York Academy of Sciences
    The New York Academy of Sciences is an independent, not-for-profit organization committed to advancing science, technology, and society worldwide since 1817. With 25,000 members in 140 countries, the Academy is creating a global community of science for the benefit of humanity. The Academy's core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Please visit us online at www.nyas.org.

     

    EmailPrint